Connecticut Innovations

Connecticut Innovations (CI) serves as Connecticut's strategic venture capital arm, offering financing and ongoing support to innovative, growing companies. By providing equity and debt investments, strategic guidance, and introductions to valuable partners, CI helps promising businesses thrive. ([ctinnovations.com](https://ctinnovations.com/learn-about-connecticut-innovations/who-we-are/?utm_source=openai))

CI primarily invests in companies focusing on advanced manufacturing, bioscience, clean tech, information technology, and medical devices. The firm has invested over $675 million in innovative startups since its inception in 1995, leveraging its investments to attract additional capital and foster economic growth in Connecticut. ([nhpromisecouncil.com](https://nhpromisecouncil.com/wp-content/uploads/2025/01/2025-connecticut-innovations-ci-internships.pdf?utm_source=openai))

Notable investments include Biohaven, Arvinas, Sema4, IsoPlexus, Aventri (formerly etouches), Device42, Budderfly, and iDevices. CI also founded and managed VentureClash, a $5 million global pitch competition for early-stage companies, awarding $13.3 million to companies from 12 countries over five years. ([ctinnovations.com](https://ctinnovations.com/wp-content/uploads/2023/02/CI_Fact_Sheet.pdf?utm_source=openai))